U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

The risk for cardiovascular mortality in survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis peaks within ...

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI ...

Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund ...

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to ...

Amgen announced its plans to open a "technology and innovation" site in India last year that is focused on increasing the use ...

It’s often said that the UK and Europe lack the huge level of growth funding for later-stage startups that the US has for its ...

Objectives Tendinopathy is a frequent clinical problem and represents an extraordinary health economic and socioeconomic burden with high unmet medical needs. Recent clinical evidence suggests ...

Basel, February 24, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announces the launch of Pyzchiva®* (ustekinumab-ttwe) in the US. From today, the ...

FIGHT against cancer demands urgency, collaboration and innovation. With this, the Philippine National Cancer Summit (PNCS) 2025 is a clarion call to action, rallying the nation's foremost health care ...

In the first episode of a six-part interview series on immunotherapy, Mark Folke, CEO and Executive Director of Immutep (ASX:IMM), discusses the significance and rapid growth of immuno-oncology.